Novita Therapeutics, LLC — Form D/A
Novita Therapeutics, LLC of Olathe, KS, a company, filed a Form D amendment with the SEC on 2013-10-21. $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-10-21
- Form: D/A
- Accession: 0001467894-13-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $3.2M
- Investors: 26
- Date of first sale: 2012-07-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-180424
Issuer
- Name: Novita Therapeutics, LLC
- CIK: 0001467894
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1090 S. Clay Blair Blvd., Olathe, KS, 66061
- Phone: 913 440 4439
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| F. Nicholas Franano | Executive Officer | Waltham, MA |
| William P Whitaker | Executive Officer | Fairway, KS |
Other filings by this issuer (4)
More